MedPath

Infections after hysterectomy - a placebo controlled study comparing the profylactic use of azithromycin and cefuroxime with single cefuroxime

Phase 4
Not yet recruiting
Conditions
Undergoing hysterectomy
Registration Number
2024-517508-12-00
Lead Sponsor
HUS-Yhtymae
Brief Summary

To study post-hysterectomy infections and to compare the use of azithromycin and cefuroxime vs single cefuroxime in antibiotic prophylaxis

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised, recruitment pending
Sex
Female
Target Recruitment
2278
Inclusion Criteria

Women undergoing hysterectomy for a benign indication in a public hospital in Finland who have not any contraindications for azithromycin or cefuroxime. The person must understand the information given in finnish or swedish.

Exclusion Criteria

Inability to understand the study protocol. Allergy for either cefuroxime or azithromycin. Congenital or acquired prolonged QTc interval. Use of medicines that may prolong QTc interval (class Ia arrhythmia medications, quinidine, procainamide, and class III arrhythmia medications dofetilidi, amiodarone and sotalol). Use of SSRI medication and prolonged QTc interval.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deep wound and pelvic organ infections up to 30 days postoperatively

Deep wound and pelvic organ infections up to 30 days postoperatively

Secondary Outcome Measures
NameTimeMethod
Surficial infections and other infections, such has urine tract infections, and fever over 38 ℃ over 2 days.

Surficial infections and other infections, such has urine tract infections, and fever over 38 ℃ over 2 days.

Trial Locations

Locations (6)

Kuopio University Hospital

🇫🇮

Kuopio, Finland

Keski-Suomen Hyvinvointialue

🇫🇮

Finland

HUS-Yhtymae

🇫🇮

Helsinki, Finland

Oulu University Hospital

🇫🇮

Oulu, Finland

Turku University Hospital

🇫🇮

Turku, Finland

Tampere University Hospital

🇫🇮

Tampere, Finland

Kuopio University Hospital
🇫🇮Kuopio, Finland
Henna Kärkkäinen
Site contact
0447172741
henna.karkkainen@kuh.fi

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.